Literature DB >> 17157783

RAS unplugged: negative feedback and oncogene-induced senescence.

Nabeel Bardeesy1, Norman E Sharpless.   

Abstract

Many normal cells respond to certain stresses, such as oncogene activation, by undergoing a permanent form of growth arrest known as senescence, an intrinsic tumor suppressor program. The predominant view has been that senescence is caused in some settings through a mutant oncogene's ability to induce activation of high levels of sustained MAP kinase and PI3 kinase signaling. A new study in this issue of Cancer Cell has challenged this model with the surprising finding that aberrant activation of the RAS/RAF pathway can induce a negative feedback loop that globally attenuates MAPK and PI3K signaling and that the reduction of signaling in these pathways is required for senescence.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17157783     DOI: 10.1016/j.ccr.2006.11.015

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  10 in total

1.  In vitro models of pancreatic cancer for translational oncology research.

Authors:  Georg Feldmann; Sherri Rauenzahn; Anirban Maitra
Journal:  Expert Opin Drug Discov       Date:  2009-04-01       Impact factor: 6.098

Review 2.  Tnk1/Kos1: a novel tumor suppressor.

Authors:  William Stratford May; Kishalay Hoare; Sarasija Hoare; Mary K Reinhard; Young J Lee; S Paul Oh
Journal:  Trans Am Clin Climatol Assoc       Date:  2010

3.  Widespread activation of the DNA damage response in human pancreatic intraepithelial neoplasia.

Authors:  Jan-Bart M Koorstra; Seung-Mo Hong; Chanjuan Shi; Alan K Meeker; Ji Kon Ryu; George Johan A Offerhaus; Michael G Goggins; Ralph H Hruban; Anirban Maitra
Journal:  Mod Pathol       Date:  2009-08-07       Impact factor: 7.842

4.  Oncogenic KRAS sensitises colorectal tumour cells to chemotherapy by p53-dependent induction of Noxa.

Authors:  M T de Bruijn; D A E Raats; F J H Hoogwater; W J van Houdt; K Cameron; J P Medema; I H M Borel Rinkes; O Kranenburg
Journal:  Br J Cancer       Date:  2010-03-30       Impact factor: 7.640

Review 5.  Pancreatic cancer.

Authors:  Anirban Maitra; Ralph H Hruban
Journal:  Annu Rev Pathol       Date:  2008       Impact factor: 23.472

Review 6.  Pumping the brakes on RAS - negative regulators and death effectors of RAS.

Authors:  Desmond R Harrell Stewart; Geoffrey J Clark
Journal:  J Cell Sci       Date:  2020-02-10       Impact factor: 5.285

7.  Spontaneous induction of murine pancreatic intraepithelial neoplasia (mPanIN) by acinar cell targeting of oncogenic Kras in adult mice.

Authors:  Nils Habbe; Guanglu Shi; Robert A Meguid; Volker Fendrich; Farzad Esni; Huiping Chen; Georg Feldmann; Doris A Stoffers; Stephen F Konieczny; Steven D Leach; Anirban Maitra
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-21       Impact factor: 11.205

Review 8.  Molecular genetics of pancreatic ductal adenocarcinomas and recent implications for translational efforts.

Authors:  Georg Feldmann; Anirban Maitra
Journal:  J Mol Diagn       Date:  2008-02-07       Impact factor: 5.568

9.  Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer.

Authors:  Ching-Chieh Weng; Mei-Jen Hsieh; Chia-Chen Wu; Yu-Chun Lin; Yan-Shen Shan; Wen-Chun Hung; Li-Tzong Chen; Kuang-Hung Cheng
Journal:  Mol Cancer       Date:  2019-05-20       Impact factor: 27.401

10.  Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras.

Authors:  Sharon Y Gidekel Friedlander; Gerald C Chu; Eric L Snyder; Nomeda Girnius; Gregory Dibelius; Denise Crowley; Eliza Vasile; Ronald A DePinho; Tyler Jacks
Journal:  Cancer Cell       Date:  2009-11-06       Impact factor: 31.743

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.